Eventide Asset Management »

Belite Bio shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $15M 195k 74.00

More positions owned by Eventide Asset Management

Guardant Health (GH)
Mirum Pharmaceuticals (MIRM)
Xometry Class A Com (XMTR)
Trane Technologies SHS (TT)
Insmed Com Par $.01 (INSM)
Lam Research Corp Com New (LRCX)
Irhythm Technologies (IRTC)
Ge Vernova (GEV)
Scholar Rock Hldg Corp (SRRK)
Beta Bionics (BBNX)
Argenx Se Sponsored Adr (ARGX)
Roper Industries (ROP)
Vistra Energy (VST)
Axsome Therapeutics (AXSM)
Toast Cl A (TOST)

View all positions for Eventide Asset Management

Top funds holding Belite Bio

RA Capital Management
Rtw Investments
Vestal Point Capital
Soleus Capital Management
Eventide Asset Management
Marshall Wace
Perceptive Advisors
Millennium Management
Geode Capital Management
State Street Corporation
Bnp Paribas Arbitrage, Snc
UBS Group
Citadel Advisors
Jpmorgan Chase & Co
Polymer Capital Management

View all funds holding Belite Bio